Rosuvastatin or Citrus Bergamot: What Is the Difference

Rosuvastatin and citrus bergamot extract are often mentioned in the same context — as agents for lowering cholesterol. But there is a gulf between them: one is a prescription drug with data from large randomized trials on reducing heart attacks and strokes, the other is a dietary supplement with a limited evidence base. The editorial team explains what exactly the difference is.

A medicinal product and a dietary supplement

Rosuvastatin is a registered medicinal product from the statin group. Its effectiveness and safety were tested in randomized trials on tens of thousands of people, and its production complies with pharmaceutical quality standards: each tablet contains the declared amount of the active substance.

Bergamot extract (Citrus bergamia) is a product from the fruit of a citrus tree cultivated mainly in Calabria in southern Italy. In most countries it is sold as a dietary supplement. Such products do not undergo registration clinical trials, and the requirements for standardizing the composition are much softer.

This status determines not only the evidence base but also the responsibility: a drug manufacturer is obliged to prove the effect, whereas a supplement manufacturer merely must not violate food safety requirements. Therefore, the advertising promises on supplement labels should not be taken as clinical fact.

It is correct to compare these products only with an understanding of this difference. Next we will look at the mechanisms, study data and safety of both.

How rosuvastatin works

Rosuvastatin inhibits the enzyme HMG-CoA reductase, which limits the rate of cholesterol synthesis in the liver. When less of one’s own cholesterol is produced, liver cells increase the number of low-density lipoprotein (LDL) receptors on their surface and take them up from the blood more actively. As a result, the level of “bad” cholesterol decreases.

Rosuvastatin is a hydrophilic statin with a long half-life (about 19 hours). It depends little on the enzyme CYP3A4, through which atorvastatin and simvastatin are metabolized, so it has fewer interactions with drugs and products that affect this enzyme.

In terms of strength of action, rosuvastatin is one of the most potent statins. At doses of 20–40 mg it belongs to high-intensity therapy, which lowers LDL on average by 50% and more; at doses of 5–10 mg — to moderate intensity.

Statins also have so-called pleiotropic effects: reducing inflammation in the vessel wall, stabilizing atherosclerotic plaques. Illustrative is the JUPITER study (Ridker et al., 2008), in which rosuvastatin, in people with normal LDL but elevated C-reactive protein, substantially reduced the rate of cardiovascular events.

What bergamot contains and how it supposedly works

The juice and peel of bergamot are rich in flavonoids: naringin, neohesperidin, neoeriocitrin. In addition, specific compounds were found in bergamot — brutieridin and melitidin, whose structure partly resembles statins. On this basis, manufacturers claim that the extract gently inhibits cholesterol synthesis.

Other proposed mechanisms are antioxidant action, an effect on the enzymes of lipid metabolism and improved insulin sensitivity. However, most of these data were obtained in cell cultures and animals, and in humans they are mostly not confirmed by direct measurements.

A review by Mollace and co-authors (2011) described a reduction in total cholesterol, LDL and triglycerides after taking the polyphenolic fraction of bergamot in small studies. A systematic review by Lamiquiz-Moneo and colleagues (2020) also found favorable changes in lipids, but pointed to small samples, different products and doses, and generally low study quality.

Important: for bergamot there is not a single study that would show a reduction in the rate of heart attacks, strokes or mortality. All the data concern only laboratory indicators.

Comparison of the evidence base

A meta-analysis by the Cholesterol Treatment Trialists (2010), which combined data from more than 170 thousand participants, showed: every reduction in LDL by 1 mmol/L with statins reduces the risk of major vascular events by about a fifth. This relationship underlies current lipid recommendations.

A direct comparison of a statin with popular supplements was made in the SPORT study (Laffin et al., 2023). Rosuvastatin 5 mg lowered LDL by more than a third over four weeks, whereas none of the tested supplements (fish oil, cinnamon, garlic, turmeric, plant sterols, red yeast rice) produced a significant reduction compared with placebo. Bergamot was not among them, but the result illustrates well the difference between drugs and supplements.

So the question is not what is “stronger” but what has a proven benefit for heart health. Here rosuvastatin is beyond competition.

Safety and quality

The side effects of rosuvastatin are well studied. Most often — muscle symptoms (pain, weakness), less often — an increase in liver enzymes. The risk of developing diabetes mellitus rises slightly in predisposed people, but the benefit for the heart outweighs this risk in most patients. Rhabdomyolysis is a rare but serious complication.

Asian patients are prescribed rosuvastatin starting from lower doses, since the concentration of the drug in their blood is on average higher. The drug is also contraindicated in pregnancy and active liver diseases.

Bergamot was usually well tolerated in studies, with isolated complaints about digestion. However, the main risks of supplements are related to quality: an inconsistent amount of active substances, possible impurities, and in some products — compounds such as bergamottin, capable, like the substances of grapefruit, of affecting the enzymes of drug metabolism.

• Choose products with independent quality certification.
• Inform your doctor about any supplements, especially if you are taking statins, anticoagulants or antiarrhythmic drugs.
• Do not replace a prescribed statin with a supplement without consultation.

Editorial conclusions

Rosuvastatin and bergamot differ in status, mechanism and, most importantly, in evidence base. Rosuvastatin lowers not only laboratory indicators but also the rate of heart attacks and strokes.

For bergamot there are only small studies of the effect on lipids, the results of which are inconsistent, and there are no data on hard endpoints.

The supplement is not an alternative to a statin for people at high risk, and its quality strongly depends on the manufacturer.

About the practical choice, read the article “Rosuvastatin vs Citrus Bergamot: What to Choose and for Whom.” We also recommend the materials “Atorvastatin or Ezetimibe: What Is the Difference” and on the lipid profile for athletes.

References

1. Ridker PM, Danielson E, Fonseca FA, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359(21):2195–2207.
2. Cholesterol Treatment Trialists' (CTT) Collaboration; Baigent C, Blackwell L, et al. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet. 2010;376(9753):1670–1681.
3. Laffin LJ, Bruemmer D, Garcia M, et al. Comparative effects of low-dose rosuvastatin, placebo, and dietary supplements on lipids and inflammatory biomarkers. J Am Coll Cardiol. 2023;81(1):1–12.
4. Mollace V, Sacco I, Janda E, et al. Hypolipemic and hypoglycaemic activity of bergamot polyphenols: from animal models to human studies. Fitoterapia. 2011;82(3):309–316.
5. Lamiquiz-Moneo I, et al. Effect of bergamot on lipid profile in humans: a systematic review. Crit Rev Food Sci Nutr. 2020.
6. Mach F, Baigent C, Catapano AL, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020;41(1):111–188.